Sections News

Questionnaire for clinicians and units directly treating very underweight patients with Anorexia Nervosa

Tuesday, 15 March 2016 14:51

Prof Alastair Forbes, Chairman of the Small Bowel and Nutrition Section

Most gastroenterologists find themselves dealing with patients with anorexia nervosa at least occasionally and many of you will be familiar with the MARSIPAN guidance produced in conjunction with and on behalf of the Royal Colleges of Physicians, Pathologists and Psychiatrists. MARSIPAN of course stands not for the confectionery but for MAnagement of the Really SIck Patient with Anorexia Nervosa!

This e-mail address is being protected from spambots. You need JavaScript enabled to view it heads the MARSIPAN group and is keen for feedback on how uptake of the guidance has affected patient care (if at all) and would be very grateful for your time in completing the attached short questionnaire. Please return it to him and not to the BSG.

  Download survey

BAPEN Nutritional Care Tool

Thursday, 04 February 2016 14:09

Many organisations have had a heavy reliance on auditing of nutritional screening but few organisations have really focused on measuring the quality of nutritional care delivered; hence few are able, with any degree of confidence, to be assured that they are fully compliant with current regulations. The new nutritional care tool, developed by BAPEN with support from the core groups; the national nurses nutrition group (NNNG), the Parenteral and Enteral Nutrition group (PENG) of the British Dietetic Association and Patients on Intravenous and Nasogastric Nutrition Therapy (PINNT) provides a local improvement measurement tool which enables the measurement of the quality of nutritional care.

New Global Enteral Device Connector

Tuesday, 04 August 2015 09:59

Dr Sheldon Cooper (Chair, BAPEN Medical) & Prof Alastair Forbes (Chair, BSG Small Bowel & Nutrition Committee)

A new International Standard (ISO 80369-3) is being published this year and covers all connectors on enteral devices.

In order to comply with the International Standard, a new global enteral feeding device connector design (named ENFit) will be introduced across the UK from September 2015. The ENFit introduction will be a 2-stage process, with transition giving sets and gravity sets made available from September 2015, followed by ENFit feeding tubes and syringes being introduced from March 2016.

To facilitate the smooth transition to the ISO standard, a group made up of industry, clinical and NHS stakeholders was formed and named the EPSG (Enteral Plastic Safety Group). The EPSG represents all leading UK enteral feeding devices suppliers, with clinical representation from the PENG of the BDA, NNNG and supported by PINNT, BAPEN and BPNG. The following companies are members of the EPSG: Abbott; Corpak; Covidien; Fresenius Kabi; GBUK Enteral (Enteral UK); Intervene; Medicina; Nutricia; Vygon. EPSG member companies and NHS Supply Chain have agreed not to place any ENFit enteral feeding device (other than transition giving sets and gravity sets) into the UK market until 14th March 2016. It is envisaged that this process will minimise disruption to the NHS, whilst maintaining patient safety at all times. For further information about ENFit and how the changeover affects you and your patients, please contact your current enteral devices supplier or any of the following represented clinical groups: PENG of the BDA, NNNG, PINNT, BAPEN, BPNG.

What's hot in coeliac disease?

Thursday, 23 April 2015 09:05

Coeliac disease occurs when genetically predisposed individuals are exposed to dietary gluten. The clinical presentation of coeliac disease can be diverse, extending far beyond the traditional malabsorptive symptoms, and asymptomatic disease is generally identified by screening. At present, a gluten-free diet is the only available therapy for coeliac disease.

Online Course: Feeding Difficulties in Children with Gastrointestinal Disorders

Wednesday, 01 October 2014 12:59

Although feeding difficulties are a common phenomenon in children with gastrointestinal disorders, symptoms are often not recognised early enough, preventing early management and the escalation of symptoms. It is important that healthcare professionals familiarise themselves with this topic, as difficulties may impact on both the child's growth and development as well as the wider psychological well-being of the child and family.

This teaching module explains current evidence as well as addressing some of the more practical issues of management, which may assist you in your daily practice.

Page 1 of 2